日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo

聚（ADP-核糖）聚合酶抑制剂奥拉帕尼和泛 ErbB 抑制剂来那替尼在体外和体内对 HER2 过度表达的上皮性卵巢癌具有高度协同作用

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2023.01.015
Chanhee Han, Blair McNamara, Stefania Bellone, Justin Harold, Paola Manara, Tobias Max Philipp Hartwich, Levent Mutlu, Yang Yang-Hartwich, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Z Verzosa, Gary Altwerger, Elena Ratner, Gloria S Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter R
肿瘤
卵巢癌
发表日期：2023
文献求助 收藏

Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor

卵巢癌和子宫癌肉瘤在体内和体外均对 elimusertib 敏感，后者是一种新型共济失调毛细血管扩张症和 Rad3 相关 (ATR) 激酶抑制剂

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2022.12.003
Diego D Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Levent Mutlu, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Verzosa, Gary Altwerger, Elena Ratner, Gloria S Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E Schwartz, 
肿瘤
卵巢癌
发表日期：2023
文献求助 收藏

Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma

HUWE1/c-MYC 通路紊乱导致宫颈癌对 BET 溴结构域抑制剂 GS-626510 敏感

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2020.06.484
Elena Bonazzoli, Stefania Bellone, Luca Zammataro, Barbara Gnutti, Adele Guglielmi, Silvia Pelligra, Nupur Nagarkatti, Paola Manara, Joan Tymon-Rosario, Burak Zeybek, Gary Altwerger, Gulden Menderes, Chanhee Han, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Masoud Azodi, Peter E Sc
信号转导
肿瘤
宫颈癌
WB
发表日期：2020
文献求助 收藏

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

过度表达人类滋养层细胞表面标志物 (Trop-2) 的宫颈癌对抗体-药物偶联物 sacituzumab govitecan 高度敏感

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-020-58009-3
Burak Zeybek, Aranzazu Manzano, Anna Bianchi, Elena Bonazzoli, Stefania Bellone, Natalia Buza, Pei Hui, Salvatore Lopez, Emanuele Perrone, Paola Manara, Luca Zammataro, Gary Altwerger, Chanhee Han, Joan Tymon-Rosario, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Masoud Azodi, Pete
肿瘤
宫颈癌
其它细胞
Human
发表日期：2020
文献求助 收藏

PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib

PARP-1 活性 (PAR) 决定宫颈癌对奥拉帕尼的敏感性

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2019.08.010
Anna Bianchi, Salvatore Lopez, Gary Altwerger, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Aranzazu Manzano, Paola Manara, Emanuele Perrone, Burak Zeybek, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Masoud Azodi, Justin Y Newberg, Dean C Pavlick, Julia Elvin, 
肿瘤
宫颈癌
WB
发表日期：2019
文献求助 收藏

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

PIK3CA 致癌突变是 HER2/neu 过度表达的子宫浆液性癌对曲妥珠单抗产生耐药性的主要机制

期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/bjc.2015.306
Jonathan D Black, Salvatore Lopez, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Carlton L Schwab, Diana P English, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Alessandro D Santin
肿瘤
WB
发表日期：2015
文献求助 收藏

Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

HER2/PIK3CA 双靶向治疗在体内和体外克服了 HER2 扩增子宫浆液性癌细胞系中单药获得性耐药性

期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-15-0383
Salvatore Lopez, Emiliano Cocco, Jonathan Black, Stefania Bellone, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Carlton L Schwab, Diana P English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Corrado Terranova, Roberto Angioli, Alessandro D Santin
肿瘤
肿瘤细胞
Cell sorting
FCM
WB
发表日期：2015
文献求助 收藏

Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients

聚合酶 ε (POLE) 超突变肿瘤在子宫内膜癌患者中诱导强烈的肿瘤特异性 CD4+ T 细胞反应

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2015.04.027
Stefania Bellone, Floriana Centritto, Jonathan Black, Carlton Schwab, Diana English, Emiliano Cocco, Salvatore Lopez, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Dan-Arin Silasi, Elena Ratner, Masoud Azodi, Peter E Schwartz, Alessandro D Santin
肿瘤
子宫内膜癌
肿瘤细胞
发表日期：2015
文献求助 收藏

Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro

达克替尼 (PF-00299804) 是一种第二代不可逆泛 erbB 受体酪氨酸激酶抑制剂，体外对 HER2 扩增的子宫浆液性子宫内膜癌表现出显著的活性

期刊:Tumor Biology
影响因子:
doi:10.1007/s13277-015-3218-4
Liancheng Zhu, Salvatore Lopez, Stefania Bellone, Jonathan Black, Emiliano Cocco, Tiffany Zigras, Federica Predolini, Elena Bonazzoli, Beatrice Bussi, Zachary Stuhmer, Carlton L Schwab, Diana P English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Thomas J Rutherford, Alessandro D
肿瘤
子宫内膜癌
发表日期：2015
文献求助 收藏

Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel

肿瘤微环境中 III 类 β-微管蛋白过度表达是接受新辅助卡铂/紫杉醇治疗的卵巢癌患者总体生存率较差的预后生物标志物

期刊:Clinical & Experimental Metastasis
影响因子:4.2
doi:10.1007/s10585-013-9614-5
Dana M Roque, Natalia Buza, Michelle Glasgow, Stefania Bellone, Ileana Bortolomai, Sara Gasparrini, Emiliano Cocco, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas J Rutherford, Peter E Schwartz, Alessandro D Santin
肿瘤
卵巢癌
发表日期：2014
文献求助 收藏